Tiam1/Rac1 complex controls Il17a transcription and autoimmunity

44Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

RORγt is a master transcription factor of Th17 cells and considered as a promising drug target for the treatment of autoimmune diseases. Here, we show the guanine nucleotide exchange factor, Tiam1, and its cognate Rho-family G protein, Rac1, regulate interleukin (IL)17A transcription and autoimmunity. Whereas Tiam1 genetic deficiency weakens IL-17A expression partially and inhibits the development of experimental autoimmune encephalomyelitis (EAE), deletion of Rac1 in T cells exhibits more robust effects on Th17 cells and EAE. We demonstrate Tiam1 and Rac1 form a complex with RORγt in the nuclear compartment of Th17 cells, and together bind and activate the Il17 promoter. The clinical relevance of these findings is emphasized by pharmacological targeting of Rac1 that suppresses both murine and human Th17 cells as well as EAE. Thus, our findings highlight a regulatory pathway of Tiam1/Rac1 in Th17 cells and suggest that it may be a therapeutic target in multiple sclerosis.

Cite

CITATION STYLE

APA

Kurdi, A. T., Bassil, R., Olah, M., Wu, C., Xiao, S., Taga, M., … Elyaman, W. (2016). Tiam1/Rac1 complex controls Il17a transcription and autoimmunity. Nature Communications, 7. https://doi.org/10.1038/ncomms13048

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free